Carcinogenesis, Vol. 21, No. 6, 1149-1155,
June 2000
© 2000 Oxford University Press
Molecular Epidemiology and Cancer Prevention |
Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression
Division of Basic Research, South Carolina Cancer Center, Columbia, SC 29203,
1 Department of Gastrointestinal Medical Oncology and Digestive Diseases and
2 Division of Veterinary Medicine and Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030 and
3 Chemoprevention Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892, USA
We assessed the effects of 78 potential chemopreventive agents in the F344 rat using two assays in which the inhibition of carcinogen-induced aberrant crypt foci (ACF) in the colon was the measure of efficacy. In both assays ACF were induced by the carcinogen azoxymethane (AOM) in F344 rats by two sequential weekly injections at a dose of 15 mg/kg. Two weeks after the last AOM injection, animals were evaluated for the number of aberrant crypts detected in methylene blue stained whole mounts of rat colon. In the initiation phase protocol agents were given during the period of AOM administration, whereas in the post-initiation assay the chemopreventive agent was introduced during the last 4 weeks of an 8 week assay, a time when ACF had progressed to multiple crypt clusters. The agents were derived from a priority listing based on reports of chemopreventive activity in the literature and/or efficacy data from in vitro models of carcinogenesis. During the initiation phase carboxyl amidoimidazole, p-chlorphenylacetate, chlorpheniramine maleate, D609, diclofenac, etoperidone, eicosatetraynoic acid, farnesol, ferulic acid, lycopene, meclizine, methionine, phenylhexylisothiocyanate, phenylbutyrate, piroxicam, 9-cis-retinoic acid, S-allylcysteine, taurine, tetracycline and verapamil were strong inhibitors of ACF. During the post-initiation phase aspirin, calcium glucarate, ketoprofen, piroxicam, 9-cis-retinoic acid, retinol and rutin inhibited the outgrowth of ACF into multiple crypt clusters. Based on these data, certain phytochemicals, antihistamines, non-steroidal anti-inflammatory drugs and retinoids show unique preclinical promise for chemoprevention of colon cancer, with the latter two drug classes particularly effective in the post-initiation phase of carcinogenesis.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. M. Lindzon, A. Medline, K.-J. Sohn, F. Depeint, R. Croxford, and Y.-I. Kim Effect of folic acid supplementation on the progression of colorectal aberrant crypt foci Carcinogenesis, September 1, 2009; 30(9): 1536 - 1543. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. NAKAYAMA, Y. INOUE, N. MINAGAWA, K. ONITSUKA, J. NAGATA, K. SHIBAO, K. HIRATA, T. SAKO, N. NAGATA, and K. YAMAGUCHI Chemopreventive Effect of 4-[3,5-Bis(trimethylsilyl) benzamido] Benzoic Acid (TAC-101) on MNU-induced Colon Carcinogenesis in a Rat Model Anticancer Res, June 1, 2009; 29(6): 2059 - 2065. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Saidak, R. Mentaverri, and E. M. Brown The Role of the Calcium-Sensing Receptor in the Development and Progression of Cancer Endocr. Rev., April 1, 2009; 30(2): 178 - 195. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Bass, P. Sienkiewicz, C. J. MacDonald, R. Y.S. Cheng, A. Sparatore, P. Del Soldato, D. D. Roberts, T. W. Moody, D. A. Wink, and G. C. Yeh Novel Dithiolethione-Modified Nonsteroidal Anti-Inflammatory Drugs in Human Hepatoma HepG2 and Colon LS180 Cells Clin. Cancer Res., March 15, 2009; 15(6): 1964 - 1972. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-I. Kim Folic Acid Supplementation and Cancer Risk: Point Cancer Epidemiol. Biomarkers Prev., September 1, 2008; 17(9): 2220 - 2225. [Full Text] [PDF]
|
|
|
|
|
|
G. Bobe, L. B. Sansbury, P. S. Albert, A. J. Cross, L. Kahle, J. Ashby, M. L. Slattery, B. Caan, E. Paskett, F. Iber, et al. Dietary Flavonoids and Colorectal Adenoma Recurrence in the Polyp Prevention Trial Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1344 - 1353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L Ziliotto, L. Barbisan, and M. Rodrigues Lack of chemoprevention of dietary Agaricus blazei against rat colonic aberrant crypt foci Human and Experimental Toxicology, June 1, 2008; 27(6): 505 - 511. [Abstract] [PDF]
|
|
|
|
 |
|
 R. A. Furtado, E. P. Rodrigues, F. R. R. Araujo, W. L. Oliveira, M. A. Furtado, M. B. Castro, W. R. Cunha, and D. C. Tavares Ursolic Acid and Oleanolic Acid Suppress Preneoplastic Lesions Induced by 1,2-Dimethylhydrazine in Rat Colon Toxicol Pathol, June 1, 2008; 36(4): 576 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. L. Cho, M. Redston, A. G. Zauber, A. M. Carothers, J. Hornick, A. Wilton, S. Sontag, N. Nishioka, F. M. Giardiello, J. R. Saltzman, et al. Aberrant Crypt Foci in the Adenoma Prevention with Celecoxib Trial Cancer Prevention Research, June 1, 2008; 1(1): 21 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Xiao, X. Hao, B. Simi, J. Ju, H. Jiang, B. S. Reddy, and C. S. Yang Green tea polyphenols inhibit colorectal aberrant crypt foci (ACF) formation and prevent oncogenic changes in dysplastic ACF in azoxymethane-treated F344 rats Carcinogenesis, January 1, 2008; 29(1): 113 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. N. T. Ngo, D. B. Williams, L. Cobiac, and R. J. Head Does Garlic Reduce Risk of Colorectal Cancer? A Systematic Review J. Nutr., October 1, 2007; 137(10): 2264 - 2269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Aleksunes and J. E. Manautou Emerging Role of Nrf2 in Protecting Against Hepatic and Gastrointestinal Disease Toxicol Pathol, June 1, 2007; 35(4): 459 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Quann, F. Khwaja, K. H. Zavitz, and D. Djakiew The Aryl Propionic Acid R-Flurbiprofen Selectively Induces p75NTR-Dependent Decreased Survival of Prostate Tumor Cells Cancer Res., April 1, 2007; 67(7): 3254 - 3262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. K. Glebov, L. M. Rodriguez, P. Soballe, J. DeNobile, J. Cliatt, K. Nakahara, and I. R. Kirsch Gene Expression Patterns Distinguish Colonoscopically Isolated Human Aberrant Crypt Foci from Normal Colonic Mucosa. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2253 - 2262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Wargovich What Do Diet-Induced Alterations in Colorectal Polyps and Aberrant Crypts Indicate for Risk? J. Nutr., October 1, 2006; 136(10): 2679S - 2680S. [Full Text] [PDF]
|
|
|
|
|
|
T. P. Ong, R. Heidor, A. de Conti, M. L. Z. Dagli, and F. S. Moreno Farnesol and geraniol chemopreventive activities during the initial phases of hepatocarcinogenesis involve similar actions on cell proliferation and DNA damage, but distinct actions on apoptosis, plasma cholesterol and HMGCoA reductase Carcinogenesis, June 1, 2006; 27(6): 1194 - 1203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Ross, J. W. Finley, and J. A. Milner Allyl Sulfur Compounds from Garlic Modulate Aberrant Crypt Formation J. Nutr., March 1, 2006; 136(3): 852S - 854S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Kim, J. J. Song, J. Y. An, Y. T. Kwon, and Y. J. Lee Pretreatment of Acetylsalicylic Acid Promotes Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Apoptosis by Down-regulating BCL-2 Gene Expression J. Biol. Chem., December 9, 2005; 280(49): 41047 - 41056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Y. Park, A. Dillard, E. A. Williams, E. T. Wilder, M. R. Pepper, and M. A. Lane Retinol Inhibits the Growth of All-Trans-Retinoic Acid-Sensitive and All-Trans-Retinoic Acid-Resistant Colon Cancer Cells through a Retinoic Acid Receptor-Independent Mechanism Cancer Res., November 1, 2005; 65(21): 9923 - 9933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Vetrano, D. E. Heck, T. M. Mariano, V. Mishin, D. L. Laskin, and J. D. Laskin Characterization of the Oxidase Activity in Mammalian Catalase J. Biol. Chem., October 21, 2005; 280(42): 35372 - 35381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. D. Nadauld, D. N. Shelton, S. Chidester, H. J. Yost, and D. A. Jones The Zebrafish Retinol Dehydrogenase, rdh1l, Is Essential for Intestinal Development and Is Regulated by the Tumor Suppressor Adenomatous Polyposis Coli J. Biol. Chem., August 26, 2005; 280(34): 30490 - 30495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. de Moura Espindola, R. P. Mazzantini, T. P. Ong, A. de Conti, R. Heidor, and F. S. Moreno Geranylgeraniol and {beta}-ionone inhibit hepatic preneoplastic lesions, cell proliferation, total plasma cholesterol and DNA damage during the initial phases of hepatocarcinogenesis, but only the former inhibits NF-{kappa}B activation Carcinogenesis, June 1, 2005; 26(6): 1091 - 1099. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Rudolph, J. A. Dominitz, J. W. Lampe, L. Levy, P. Qu, S. S. Li, P. D. Lampe, M. P. Bronner, and J. D. Potter Risk Factors for Colorectal Cancer in Relation to Number and Size of Aberrant Crypt Foci in Humans Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 605 - 608. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Chakrabarty, H. Wang, L. Canaff, G. N. Hendy, H. Appelman, and J. Varani Calcium Sensing Receptor in Human Colon Carcinoma: Interaction with Ca2+ and 1,25-Dihydroxyvitamin D3 Cancer Res., January 15, 2005; 65(2): 493 - 498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Paulsen, E. M. Loberg, H. B. Olstorn, H. Knutsen, I.-L. Steffensen, and J. Alexander Flat Dysplastic Aberrant Crypt Foci Are Related to Tumorigenesis in the Colon of Azoxymethane-Treated Rat Cancer Res., January 1, 2005; 65(1): 121 - 129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. M. Sieber, K. M. Howarth, C. Thirlwell, A. Rowan, N. Mandir, R. A. Goodlad, A. Gilkar, B. Spencer-Dene, G. Stamp, V. Johnson, et al. Myh Deficiency Enhances Intestinal Tumorigenesis in Multiple Intestinal Neoplasia (ApcMin/+) Mice Cancer Res., December 15, 2004; 64(24): 8876 - 8881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Zhao, Y. Egashira, and H. Sanada Ferulic Acid Is Quickly Absorbed from Rat Stomach as the Free Form and Then Conjugated Mainly in Liver J. Nutr., November 1, 2004; 134(11): 3083 - 3088. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Jette, P. W. Peterson, I. T. Sandoval, E. J. Manos, E. Hadley, C. M. Ireland, and D. A. Jones The Tumor Suppressor Adenomatous Polyposis Coli and Caudal Related Homeodomain Protein Regulate Expression of Retinol Dehydrogenase L J. Biol. Chem., August 13, 2004; 279(33): 34397 - 34405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Femia, P. Dolara, and G. Caderni Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomarkers for colon carcinogenesis Carcinogenesis, February 1, 2004; 25(2): 277 - 281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Ziegler, L. Rainwater, J. Whelan, and M. F. McEntee Dietary Resveratrol Does Not Affect Intestinal Tumorigenesis in ApcMin/+ Mice J. Nutr., January 1, 2004; 134(1): 5 - 10. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Mollersen, J. E. Paulsen, H. B. Olstorn, H. K. Knutsen, and J. Alexander Dietary retinoic acid supplementation stimulates intestinal tumour formation and growth in multiple intestinal neoplasia (Min)/+ mice Carcinogenesis, January 1, 2004; 25(1): 149 - 153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Kopelovich, J. A. Crowell, and J. R. Fay The Epigenome as a Target for Cancer Chemoprevention J Natl Cancer Inst, December 3, 2003; 95(23): 1747 - 1757. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Carrier, A. Medline, K.-J. Sohn, M. Choi, R. Martin, S. W. Hwang, and Y.-I. Kim Effects of Dietary Folate on Ulcerative Colitis-Associated Colorectal Carcinogenesis in the Interleukin 2- and {beta}2-Microglobulin-deficient Mice Cancer Epidemiol. Biomarkers Prev., November 1, 2003; 12(11): 1262 - 1267. [Abstract] [Full Text]
|
|
|
|
 |
|
 E T Hawk and J L Viner Aspirin: still learning about the wonder drug Gut, November 1, 2003; 52(11): 1535 - 1536. [Full Text]
|
|
|
|
|
|
B Shpitz, E Klein, G Buklan, D Neufeld, A Nissan, H R Freund, M Grankin, and J Bernheim Suppressive effect of aspirin on aberrant crypt foci in patients with colorectal cancer Gut, November 1, 2003; 52(11): 1598 - 1601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-I. Kim Role of Folate in Colon Cancer Development and Progression J. Nutr., November 1, 2003; 133(11): 3731S - 3739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kotsopoulos, K.-J. Sohn, R. Martin, M. Choi, R. Renlund, C. Mckerlie, S. W. Hwang, A. Medline, and Y.-I. J. Kim Dietary folate deficiency suppresses N-methyl-N-nitrosourea-induced mammary tumorigenesis in rats Carcinogenesis, May 1, 2003; 24(5): 937 - 944. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Chakrabarty, V. Radjendirane, H. Appelman, and J. Varani Extracellular Calcium and Calcium Sensing Receptor Function in Human Colon Carcinomas: Promotion of E-Cadherin Expression and Suppression of {beta}-Catenin/TCF Activation Cancer Res., January 1, 2003; 63(1): 67 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-J. Sohn, J. M. Stempak, S. Reid, S. Shirwadkar, J. B. Mason, and Y.-I. Kim The effect of dietary folate on genomic and p53-specific DNA methylation in rat colon Carcinogenesis, January 1, 2003; 24(1): 81 - 90. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Hirose, T. Kuno, Y. Yamada, K. Sakata, M. Katayama, K. Yoshida, Z. Qiao, K. Hata, N. Yoshimi, and H. Mori Azoxymethane-induced beta-catenin-accumulated crypts in colonic mucosa of rodents as an intermediate biomarker for colon carcinogenesis Carcinogenesis, January 1, 2003; 24(1): 107 - 111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. E. Steele, C. W. Boone, D. Dauzonne, C. V. Rao, and R. V. Bensasson Correlation between Electron-donating Ability of a Series of 3-Nitroflavones and Their Efficacy to Inhibit the Onset and Progression of Aberrant Crypt Foci in the Rat Colon Cancer Res., November 15, 2002; 62(22): 6506 - 6509. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Cohen A Review of Animal Model Studies of Tomato Carotenoids, Lycopene, and Cancer Chemoprevention Experimental Biology and Medicine, November 1, 2002; 227(10): 864 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-I. Kim, M. Hayek, J. B. Mason, and S. N. Meydani Severe Folate Deficiency Impairs Natural Killer Cell-Mediated Cytotoxicity in Rats J. Nutr., June 1, 2002; 132(6): 1361 - 1367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Caderni, M.-G. Perrelli, F. Cecchini, and L. Tessitore Enhanced growth of colorectal aberrant crypt foci in fasted/refed rats involves changes in TGF{beta}1 and p21CIP expressions Carcinogenesis, February 1, 2002; 23(2): 323 - 327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Wargovich, C. Woods, D. M. Hollis, and M. E. Zander Herbals, Cancer Prevention and Health J. Nutr., November 1, 2001; 131(11): 3034S - 3036. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Zalatnai, K. Lapis, B. Szende, E. Raso, A. Telekes, A. Resetar, and M. Hidvegi Wheat germ extract inhibits experimental colon carcinogenesis in F-344 rats Carcinogenesis, October 1, 2001; 22(10): 1649 - 1652. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gupta, R. Nines, K. A. Rodrigo, R. A. Aziz, P. S. Carlton, D. L. Gray, V. E. Steele, M. A. Morse, and G. D. Stoner Effects of Dietary N-(4-Hydroxyphenyl)retinamide on N-Nitrosomethylbenzylamine Metabolism and Esophageal Tumorigenesis in the Fischer 344 Rat J Natl Cancer Inst, July 4, 2001; 93(13): 990 - 998. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Erik Paulsen, I.-L. Steffensen, E. M. Loberg, T. Husoy, E. Namork, and J. Alexander Qualitative and Quantitative Relationship between Dysplastic Aberrant Crypt Foci and Tumorigenesis in the Min/+ Mouse Colon Cancer Res., July 1, 2001; 61(13): 5010 - 5015. [Abstract] [Full Text] [PDF]
|
|